Hematology
In this section, you will find timely and clinically-relevant educational resources focused in the area of hematologic cancers. This includes video archives from conferences and other live programs, webinars, slide decks, and podcasts.
Videos
Best of ASCO® Montreal 2022: Non-Myeloma Hematology – Dr. Olivier Veilleux
Best of ASCO® Montreal 2022: Non-Myeloma...
Best of ASCO® Montreal 2022: Myeloma – Dr. Richard LeBlanc
Best of ASCO® Montreal 2022: MyelomaLearning Objectives:...
Best of ASCO® Toronto 2022: Hematology – Dr. Sita Bhella
Best of ASCO® Toronto 2022: HematologyLearning Objectives:...
ASH 2021 ROUNDTABLE DISCUSSIONS: MULTIPLE MYELOMA
Learning Objectives: ASH 2021 ROUNDTABLE DISCUSSIONS:...
ASH 2021 ROUNDTABLE DISCUSSIONS
Key Content Areas Include: ASH 2021 ROUNDTABLE...
ASH 2021 ROUNDTABLE DISCUSSIONS: LYMPHOMA
Key Content Areas Include: ASH 2021 ROUNDTABLE...
ASH 2021 ROUNDTABLE DISCUSSIONS: LEUKEMIA
Key Content Areas Include: ASH 2021 ROUNDTABLE...
BEST OF HEMATOLOGY 2022
BEST OF HEMATOLOGY 2022Key Content Areas Include: LEARNING...
BEST OF ONCOLOGY WEST: 2022 Lymphoma – Dr. Kerry Savage
BEST OF ONCOLOGY WEST: 2022 LymphomaKey Content Areas...
Highlights from ASH: Chronic Myeloid Leukemia Webinar
Key Content Areas Include: Review recent and most...
A Rapidly Changing AML Landscape: Keeping up With the Newest Advances in AML Management
Key Content Areas Include: Discuss current AML treatment...
Current Management of DLBCL patients Undergoing CAR T-Cell Therapy
Learning Objectives Review outcomes of CAR T in RR-DLBCL...
Management of B-ALL in the Era of Targeted Immunotherapy
Learning Objectives Review the clinical significance of...
Best of ASCO Vancouver 2021 – Panel Discussion: The Rising Cost of Cancer Drugs and Impact on Access
Learning Objectives To summarize the most significant...
Best of ASCO Vancouver 2021 – Lymphoma
Learning Objectives To summarize the most significant...
Best of ASCO Vancouver 2021 – Emerging role of CT DNA
Learning Objectives To summarize the most significant...
Best of ASCO Vancouver 2021 – ASCO Highlights in Real-World Evidence and Health Services Research
Learning Objectives To summarize the most significant...
EHA Roundtables – Multiple Myeloma
Learning Objectives Corresponding abstracts can be found...
Tailored Approaches to Management of Relapsed Multiple Myeloma
Learning Objectives Discuss the role of disease and...
The Dawn of New Approaches in the Treatment and Management of Patients with CLL
Learning Objectives Review emerging clinical evidence in...
EHA Roundtables – Leukemia
Learning Objectives Chair Dr. Andre SchuhSpeakers Dr....
EHA Roundtables – Lymphoma
Learning Objectives Chair Dr. Robert KridelSpeakers Dr....
Best of ASCO Montreal 2021 – Myeloma
Learning Objectives To summarize the most significant...
Best of ASCO Montreal 2021 – Practice-Changing Data
Learning Objectives To summarize the most significant...
Best of ASCO Montreal 2021 – The Impact of the COVID-19 Pandemic on Radiotherapy Services in Quebec
Learning Objectives To summarize the most significant...
Best of ASCO Montreal 2021 – Impact of COVID-19 on Clinical Oncology Practice: 10 Changes I Will Make
Learning Objectives To summarize the most significant...
New Developments in the Treatment of CLL & Practical Approaches to Patient Management – Updates from ASCO 2021
Learning Objectives Review emerging clinical evidence in...
ASCO Roundtable: Hematology
Learning objectives Summarize and provide expert opinions...
Best of ASCO Toronto 2021 – Hematology
Learning objectives To summarize the most significant...
Chronic Lymphocytic Leukemia: Practical Approaches to Managing Patients in an Evolving Treatment Landscape- Updates from ASCO 2021
Learning objectives Review emerging clinical evidence in...
Charting New Directions in the Treatment and Management of Patients with Chronic Lymphocytic Leukemia
Learning objectives Review emerging clinical evidence in...
EHA Highlights on Immune Thrombocytopenia
Learning objectives Presenting new data/key abstracts from...
Advances and Challenges in CLL: Perspectives and Insights from ASCO 2021
Learning objectives Where are we now in 2021 in the...
Multiple Myeloma Panel: A Case Based Discussion
Learning objectives Lorem ipsum dolor sit amet,...
Current Approaches to Management of Adult Relapsed/Refractory B-Cell ALL
Learning objectives Understand the rationale for choosing...
Recent Updates and Approaches for Treating Relapsed/Refractory ALL
Learning objectives Review the clinical significance of...
Hot Topics in Multiple Myeloma
Learning objetives Discuss emerging data in relapsed...
“ALL”-Hands: bridging ALL care between peds, AYAs, and adults
Learning objetives Demonstrate how collaboration between...
Measurable Residual Disease Testing
Learning objetives Discuss methodologies for MRD testing...
Insights from ASH: Chronic myeloid leukemia
Learning objetives Review recent advances in CML...
Updates and Optimizing Treatment Outcomes in AML Management
Learning objetives Review the role of SMO inhibitor and...
Optimizing Treatment Outcomes in Relapsed/Refractory ALL
Learning objetives Review the clinical significance of...
Updates and Optimizing Outcomes in Non Intensive AML Management
Learning objetives Review the role of SMO inhibitor and...
Management of frail and elderly patients with multiple myeloma (Eastern)
Learning objetives Educate HCPs on frailty assessment...
Critical Role of Treating Minimal Residual Disease in Acute Lymphoblastic Leukemia
Learning objetives The learning objectives are outlined in...
Impact of clinical and disease related factors on treatment sequencing for management of Multiple Myeloma patients
Learning objetives The learning objectives are outlined in...
Treating relapsed myeloma in patients progressing after lenalidomide therapy
Learning objetives The learning objectives are outlined in...
Podcasts
Best of ASCO® Montreal 2022: Non-Myeloma Hematology – Dr. Olivier Veilleux
Learning Objectives: Best of ASCO® Montreal 2022:...
Best of ASCO® Montreal 2022: Myeloma – Dr. Richard LeBlanc
Learning Objectives: Best of ASCO® Montreal 2022:...
Best of ASCO® Toronto 2022: Hematology – Dr. Sita Bhella
Learning Objectives: Best of ASCO® Toronto 2022:...
ASH 2021 ROUNDTABLE DISCUSSIONS: MULTIPLE MYELOMA
Learning Objectives: ASH 2021 ROUNDTABLE DISCUSSIONS:...
ASH 2021 ROUNDTABLE DISCUSSIONS
Key Content Areas Include: ASH 2021 ROUNDTABLE...
ASH 2021 ROUNDTABLE DISCUSSIONS: LEUKEMIA
Key Content Areas Include: ASH 2021 ROUNDTABLE...
ASH 2021 ROUNDTABLE DISCUSSIONS: LYMPHOMA
Key Content Areas Include: ASH 2021 ROUNDTABLE...
BEST OF HEMATOLOGY 2022
BEST OF HEMATOLOGY 2022Key Content Areas Include: LEARNING...
BEST OF ONCOLOGY WEST: 2022 Lymphoma – Dr. Kerry Savage
BEST OF ONCOLOGY WEST: 2022 LymphomaKey Content Areas...
MRD Assessment in Adult ALL…Why and How?
Learning Objectives to appreciate the importance of MRD...
Maximizing Patient Outcomes in Adult Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
Learning Objectives Discuss strategies to give patients...
Maximizing Outcomes in Relapsed Multiple Myeloma / Maximiser les résultats dans le myélome multiple récidivant
Learning Objectives L'attrition des patients dans toutes...
The Critical Role of MRD Testing in Acute Lymphoblastic Leukemia
Learning objetives Discuss the benefits of MRD testing...
Moving towards personalized approaches in multiple myeloma
Learning objetives Discuss strategies for tailoring care...
Multiple Myeloma: Treatment at first relapse
Learning objectives Review updated clinical data on...